Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moumita Chatterjee

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Autoimmunity Reviews|November 20, 2021
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysisRudra Prosad Goswami, Soumendra Nath Haldar, Moumita Chatterjee, et al.
Clinical Lung Cancer|July 1, 2015
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC PatientsErin M Bertino, Terence M Williams, S Patrick Nana-Sinkam, et al.
Pediatric Blood & Cancer|March 27, 2015
Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP)Peter J Houghton, Raushan T Kurmasheva, E Anders Kolb, et al.
Scientific Reports|June 13, 2015
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic CancerMoumita Chatterjee, Edgar Ben-Josef, Dafydd G Thomas, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Autoimmunity Reviews|November 20, 2021
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysisRudra Prosad Goswami, Soumendra Nath Haldar, Moumita Chatterjee, et al.
Clinical Lung Cancer|July 1, 2015
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC PatientsErin M Bertino, Terence M Williams, S Patrick Nana-Sinkam, et al.
Pediatric Blood & Cancer|March 27, 2015
Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP)Peter J Houghton, Raushan T Kurmasheva, E Anders Kolb, et al.
Scientific Reports|June 13, 2015
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic CancerMoumita Chatterjee, Edgar Ben-Josef, Dafydd G Thomas, et al.
Pageof 4